Cargando…

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI

BACKGROUND: Fibrolamellar hepatocellular carcinoma (FLC) is a rare malignancy occurring in young patients without cirrhosis. Objectives of our study were to analyze contrast material uptake in hepatobiliary phase imaging (HBP) in gadoxetic acid-enhanced liver MRI in patients with FLC and to characte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palm, Viktoria, Sheng, Ruofan, Mayer, Philipp, Weiss, Karl-Heinz, Springfeld, Christoph, Mehrabi, Arianeb, Longerich, Thomas, Berger, Anne Katrin, Kauczor, Hans-Ulrich, Weber, Tim Frederik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831838/ https://www.ncbi.nlm.nih.gov/pubmed/29490696 http://dx.doi.org/10.1186/s40644-018-0143-y

Ejemplares similares

Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
por: Lemekhova, Anastasia, et al.
Publicado: (2020)

Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database
por: Polychronidis, Georgios, et al.
Publicado: (2022)

Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
por: Vogeler, Marie, et al.
Publicado: (2020)

Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
por: Wehling, Cyrill, et al.
Publicado: (2021)

Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma
por: Mohr, Isabelle, et al.
Publicado: (2022)

Improving radiologic communication in oncology: a single-centre experience with structured reporting for cancer patients
por: Weber, Tim Frederik, et al.
Publicado: (2020)

Surgical management of primary liver cancers during the COVID-19 pandemic: overcoming the dilemma with standardization
por: Ramouz, Ali, et al.
Publicado: (2023)

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma
por: Graham, Rondell P, et al.
Publicado: (2018)

Pringle Maneuver in Extended Liver Resection: A propensity score analysis
por: Al-Saeedi, Mohammed, et al.
Publicado: (2020)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
por: Sheng, Ruofan, et al.
Publicado: (2021)

Long term follow up after resection emphasizes the role of surgery in Primary Hepatic Epithelioid Hemangioendothelioma
por: Mehrabi, Arianeb, et al.
Publicado: (2016)

Fibrolamellar Carcinoma: 2012 Update
por: Torbenson, Michael
Publicado: (2012)

Mixed fibrolamellar hepatocellular carcinoma
por: Limaiem, Faten, et al.
Publicado: (2021)

Quantification of liver function using gadoxetic acid-enhanced MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2020)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
por: Yoshida, Morikatsu, et al.
Publicado: (2020)

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
por: Tomczak, Aurelie, et al.
Publicado: (2022)

Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis
por: Khajeh, Elias, et al.
Publicado: (2023)

The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications—Who Is at Risk? A Collaborative Transplant Study Report
por: Lozanovski, Vladimir J., et al.
Publicado: (2020)

Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular Carcinoma
por: Lozanovski, Vladimir J., et al.
Publicado: (2019)

Fibrolamellar Carcinomas are Positive for CD68
por: Ross, Hillary M, et al.
Publicado: (2010)

Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma
por: G. Peacock, Justin, et al.
Publicado: (2013)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
por: Villa, Nicolas A., et al.
Publicado: (2015)

Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting
por: Tan, Cher Heng, et al.
Publicado: (2022)

Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition
por: Ulloa, Jose L, et al.
Publicado: (2013)

Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid–enhanced liver MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2022)

A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects
por: Polychronidis, Georgios, et al.
Publicado: (2022)

Is MRCP necessary to diagnose pancreas divisum?
por: Bogveradze, Nino, et al.
Publicado: (2019)

Infrequent chromosome allele loss in fibrolamellar carcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Mitochondrial Mutations in Hepatocellular Carcinomas and Fibrolamellar Carcinomas
por: Vivekanandan, Perumal, et al.
Publicado: (2010)

Surgical Resection of Ruptured Fibrolamellar Hepatocellular Carcinoma
por: Minutolo, Vincenzo, et al.
Publicado: (2013)

Synchronous Fibrolamellar Hepatocellular Carcinoma and Auricular Myxoma
por: González-Cantú, Yessica M., et al.
Publicado: (2015)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015)

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
por: Suarez, Oscar, et al.
Publicado: (2018)

Spontaneous Rupture of Fibrolamellar Variant Hepatocellular Carcinoma
por: Polavarapu, Abhishek D., et al.
Publicado: (2019)

Immunohistochemical detection of procalcitonin in fibrolamellar hepatocellular carcinoma
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022)

Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
por: Gummadi, Jyotsna, et al.
Publicado: (2023)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
por: Song, Kyoung Doo, et al.
Publicado: (2015)

Histogram Analysis of Gadoxetic Acid-Enhanced MRI for Quantitative Hepatic Fibrosis Measurement
por: Kim, Honsoul, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k2kg7v4he85jv3lo7t7ajn0d4c